ArticleCancer immunology, immunotherapy : CII2020

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Abdul Rafeh Naqash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.